A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants
Clinical trial NCT04448561 · COMPLETED
Trial details
- NCT number
- NCT04448561
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2020-09-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.